Search clinical trials for: combination intervention package

Total 48267 results

Hyundai Pharmaceutical Co., LTD.

Unknown

HDDO-1801 Intervention Trial

Respiratory Disease

Korea, Republic of
Celgene

Terminated

A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer (TRUST)

Pancreatic Neoplasms

Netherlands
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Lung Cancer | Adenocarcinoma of the Lung
Ian F. Pollack, M.D.
National Cancer Institute (NCI); Oncovir, Inc.

Completed

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Glioma | Astrocytoma | Oligo-Astrocytoma

United States
Nantes University Hospital

Completed

Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV (AES ODEFSEY)

Hiv

France
Iowa City Veterans Affairs Medical Center
US Department of Veterans Affairs

Completed

Tailored Tobacco Quitline for Rural Veterans

Cigarette Smoking

United States
Ministry of Health and Population, Egypt

Completed

Combination of Topiramate and Empagliflozin is Considered a Good Option for the Treatment of Obesity

Obesity

Egypt
Milton S. Hershey Medical Center
Pfizer

Completed

PF 06412562 in Subjects With Advanced Stage Parkinson's Disease

Parkinson Disease

United States
Boston University
World Bank (Lead institution); Republic of South Africa National Department...

Completed

Evaluation of South Africa's National Adherence Strategy (ENHANCE)

Hypertension | Diabetes | HIV | Tuberculosis

South Africa
Mark Vander Weg
Iowa City VA Health Care System

Unknown

Treating Smokeless Tobacco Use in Rural Veterans

Nicotine Dependence | Smokeless Tobacco

United States
Emory University

Completed

Evaluating a Latrine Use Intervention in Odisha, India

Latrine Usage

India
Tokyo University

Completed

Efficacy of Peer Counseling, Social Engagement, and Combination Interventions in Improving Depressive Symptoms of Filipino Senior Citizens

Depressive Symptoms

Philippines
University of Washington
National Institute of Mental Health (NIMH)

Completed

Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional Incentives

HIV Infections | Incentives | ART

South Africa
Vabiotech
Vietstar Biomedical Research

Completed

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B

Vietnam
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Takeda

Terminated

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Diabetes Mellitus, Type 2

China, Hong Kong
University Hospital, Brest
ERCR SPURBO

Completed

Scaling-up Packages of Interventions for Cardiovascular Disease Prevention in Selected Sites in Europe and Sub-Saharan Africa: An Implementation Research (SPICES_PHASE_1)

Cardiovascular Disease

France
King Saud University
Shah Physiotherapy Center, Delhi, India

Completed

Efficacy of Combination Therapies on Neck Pain & Muscle Tenderness in Patients With Upper Trapezius MTrPs

Myofascial Trigger Point Pain

Saudi Arabia
LUTRONIC Corporation

Unknown

Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema

Diabetic Macular Edema

Korea, Republic of
Vaccitech (UK) Limited
University of Oxford

Terminated

Improved Novel VaccIne CombinaTion InflUenza Study (INVICTUS)

Influenza

United Kingdom
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Hepatitis C Virus Infection

France, Austria, Germany, Italy
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safer Conception Intervention for HIV-1 Serodiscordant Couples (SCIP)

HIV Seropositivity | Pregnancy, High-Risk

United States, Kenya
Novo Nordisk A/S

Completed

A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2 | Diabetes

India
University of Zurich

Completed

Swiss HCVree Trial (HCVree)

Hepatitis C | HIV

Switzerland
Eisai Co., Ltd.

Completed

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

Gastric Ulcer | Duodenal Ulcer

Japan
Sherief Abd-Elsalam

Unknown

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Hepatitis C

Egypt
ViiV Healthcare
GlaxoSmithKline

Completed

A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany (DOL-ART)

Infection, Human Immunodeficiency Virus

Germany
GlaxoSmithKline

Completed

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Infections, Streptococcal

Bangladesh
Brown University

Completed

Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).

Adherence, Medication | Stimulant Abuse | PrEP Uptake

United States
University of Cambridge
The Hospital for Sick Children; Pfizer; Juvenile Diabetes Research Foundation; University... and other collaborators

Completed

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)

Type 1 Diabetes

Canada, Australia
The University of Texas Medical Branch, Galveston
Pfizer; University of Texas Southwestern Medical Center

Completed

Caduet and TLC Intervention in Metabolic Syndrome

Metabolic Syndrome
iOMEDICO AG

Completed

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone (REVLIMID-NIS)

Multiple Myeloma

Germany
Shanghai Zhongshan Hospital
Shanghai Municipal Science and Technology Commission

Withdrawn

Combination Treatment for Advanced Liver Cancer

Hepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion

China
Celgene

Completed

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer (Mainsail)

Prostate Cancer

United States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
Radboud University Medical Center
The PATH Malaria Vaccine Initiative (MVI); QIMR Berghofer Medical Research...

Completed

Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1 (CHMI-trans1)

Malaria

Netherlands
Hoffmann-La Roche

Completed

A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer

Cervical Cancer

Argentina
Kaohsiung Medical University Chung-Ho Memorial...
National Taiwan University Hospital

Completed

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy (BOLERO-CB)

Hepatitis C, Chronic

Taiwan
Bristol-Myers Squibb

Completed

Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy

Melanoma

United States
Daniel Hägi-Pedersen
Copenhagen Trial Unit, Center for Clinical Intervention Research

Completed

PAracetamol and NSAID in Combination: A Randomised, Blinded, Parallel, 4-group Clinical Trial (PANSAID)

Pain, Postoperative

Denmark
University of Edinburgh
NHS Lothian

Completed

Promoting Awareness Fetal Movements to Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial. (AFFIRM)

Pregnancy | Stillbirth | Decreased Fetal Movements Affecting Care of Mother

United Kingdom, Ireland
Besins Healthcare
Clinical Research Laboratory, CRO, Russia

Completed

Non-interventional Study of Therapy for Threatened Miscarriage

Threatened Miscarriage

Russian Federation
King Faisal Specialist Hospital & Research Center
Merck Sharp & Dohme LLC

Unknown

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Hepatitis C
Hoffmann-La Roche

Completed

A Non-Interventional Safety Study of Balsamic Bactrim

Bronchitis

Peru
Qin Ning

Unknown

Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients (NPGV)

Chronic Hepatitis b
Assistance Publique - Hôpitaux de Paris

Completed

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence (CLOSE)

Ischemic Stroke | Migraine | Patent Foramen Ovale | Atrial Septal Aneurysm

France
Pawel Kalinski

Withdrawn

A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Tallahassee Research Institute, Inc.
Boston Scientific Corporation

Completed

Ultrasound Comparison of Radial Artery Hyperplasia After Use of a 7F Sheathless Guide vs. 6F Sheath/Guide Combination (PRAGMATIC)

Coronary Artery Disease
Hassane M. Zarour, MD
National Cancer Institute (NCI)

Completed

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

NY-ESO-1-expressing Tumors

United States
Mark Vander Weg
VA Office of Research and Development

Unknown

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

Tobacco Use | Nicotine Dependence

United States
UbiVac
National Cancer Institute (NCI); Mayo Clinic; Louisiana State University Health... and other collaborators

Completed

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States

3

Subscribe